Ugwumba Chidozie 13D and 13G filings for Finch Therapeutics Group, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2023-12-13 5:20 pm Purchase |
2023-12-08 | 13G | Finch Therapeutics Group, Inc. FNCH |
Ugwumba Chidozie | 160,366 9.990% |
43,699![]() (+37.46%) |
Filing |
2022-02-14 3:46 pm Purchase |
2021-12-31 | 13G | Finch Therapeutics Group, Inc. FNCH |
Ugwumba Chidozie | 116,667 7.370% |
116,667![]() (New Position) |
Filing |